We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| ProShares UltraShort Financials New | AMEX:SKF | AMEX | Exchange Traded Fund |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 9.83 | 0 | 09:03:18 |
From Nov 2019 to Nov 2024
Czech generic drug maker Zentiva NV (BAAZEN.PR) Friday said it will issue 986,520 new ordinary shares to cover stock options ahead of Sanofi-Aventis SA's (2057.FR) expected EUR1.8 billion takeover of the company, according to a Zentiva statement.
"The new shares will cover in-the-money employee stock options which have been conditionally exercised by existing and former employees of Zentiva group in anticipation of a change-of-control event: the successful completion of the recommended takeover by Sanofi-Aventis," the statement said.
The subscription share price will be 1,150 koruna ($51.5) a share, and all new shares will be tendered into the Sanofi-Aventis offer, Zentiva said.
It added that if the Sanofi-Aventis offer doesn't proceed to settlement, the shares won't be issued.
Zentiva Web site: www.zentiva.cz
-By Sean Carney, Dow Jones Newswires; +420 222 191 375; sean.carney@dowjones.com
1 Year ProShares UltraShort Fin... Chart |
1 Month ProShares UltraShort Fin... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
